Search

everythinglearnresearchcommunity

for

Search:↓

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

A substance called DKK-1 increases in balding areas and causes hair cells to die when exposed to DHT.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Dihydrotestosterone increases certain inflammatory signals in skin cells, potentially contributing to acne.

DHT stops hair regrowth in mice, similar to human hair loss.

Dihydrotestosterone affects hair growth by changing the Wnt/β-catenin pathway, with low levels helping and high levels hindering growth.

Dihydrotestosterone (DHT) doesn't affect rat skin cell growth, but it does change cell cycle, protein levels, and other cell functions, potentially shortening hair growth cycle.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

Dihydrotestosterone treatment on 2D and 3D-cultured skin cells slows down hair growth by affecting certain genes and could be a potential target for hair loss treatment.

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

Dihydrotestosterone has a reduced effect on muscle-building in people with testicular feminization syndrome, especially after their gonads are removed.

Dihydrotestosterone changes some hormone-related gene expressions in rat pituitary glands but doesn't affect the estrous cycle.

Dihydrotestosterone gel before hypospadias surgery led to less scarring but raised concerns about potential psychological effects and skin changes.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

Dihydrotestosterone increases arterial stiffness in female mice without changing blood pressure or aortic wall thickness.

Dihydrotestosterone (DHT) and its active metabolites play a key role in various diseases, and the development of 5α-reductase inhibitors can help treat these conditions.

Dihydrotestosterone and 5α-Reductase play a role in hair loss and prostate health, and finasteride can increase hair growth in men without affecting sperm production, but it doesn't work for postmenopausal women with hair loss.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Certain finger length ratios and body hair patterns may predict side effects from birth control pills in women.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Higher DHT levels are linked to worse heart changes in severe aortic valve stenosis patients.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.